Cardiac Rhythm Disorder
Conditions
Brief summary
This study will provide ongoing, high quality data on the safety, performance, and clinical benefits of Abbott's EP devices in a real-world setting.
Interventions
Standard of care mapping and/or ablation
Sponsors
Study design
Eligibility
Inclusion criteria
* Subject underwent an electrophysiology imaging (diagnostic procedure) and/or ablation procedure that used one or more Abbott devices covered by this Registry. * Subject is willing and able to comply with the site's standard of care follow-up schedule.
Exclusion criteria
* Subject is currently participating in another clinical investigation that may confound the results of this Registry.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The proportion of patients with a device- and/or procedure-related Serious Adverse Event | 7-days | that occurred within 7-days of the procedure. |
| The proportion of procedures that achieved acute success. | Baseline | — |
Countries
Austria, Czechia, France, Germany, Hungary, India, Italy, Netherlands, Portugal, Spain
Contacts
Abbott